News Conference News TCT 2025 Trials Bolster Alternatives to Intravascular Lithotripsy for Calcified Lesions Todd Neale October 26, 2025
News Daily News Real-life Patients Do Well With Intravascular Lithotripsy: Spanish Registry Caitlin E. Cox March 01, 2024
News Conference News ACC 2023 Stable CAD Plaque Morphology Improved by PCSK9 Inhibitors: YELLOW III Shelley Wood March 04, 2023
Presentation TCT 2022 TCT 594: Impact of Arterial Access Site for Coronary Intravascular Lithotripsy Treatment of Severely Calcified Coronary Lesions: A Patient-Level Pooled Analysis of the Disrupt CAD III and CAD IV Studies Presenter: Alyssa Corley September 19, 2022
Presentation TCT 2022 TCT 177: Intravascular Lithotripsy for Treatment of Severely Calcified Coronary Lesions: Final 2-Year Results from the Disrupt CAD III Study Presenter: Matthew Price September 18, 2022
News Conference News TCT 2021 Disrupt CAD III Shows Sustained Benefit for Lithotripsy at 1 Year L.A. McKeown November 05, 2021
News Daily News FDA Approves Shockwave Intravascular Lithotripsy for Calcified Coronaries Shelley Wood February 16, 2021
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for October 2020 Shelley Wood October 30, 2020
News Conference News TCT 2020 DISRUPT CAD III: Lithotripsy Boosts Stent Expansion in Highly Calcified Lesions L.A. McKeown October 15, 2020
Presentation TCT 2020 Intravascular Lithotripsy for Treatment of Severely Calcified Coronary Artery Disease: The Disrupt CAD III Study Presenter: Dean J. Kereiakes October 15, 2020
Presentation TCT 2020 TCT 404: Intravascular Lithotripsy for Treatment of Severely Calcified Coronary Stenoses: Results From the Disrupt CAD III Optical Coherence Tomography Sub-study Presenter: Richard Shlofmitz October 14, 2020
News Opinion Editor's Corner TCT 2020 TCT 2020: Short DAPT, Longer TAVR Outcomes, Intravascular Imaging, and More Shelley Wood October 09, 2020
News Daily News Large UK Study Explores Use of Excimer Laser Coronary Atherectomy Todd Neale September 25, 2020
News Conference News TCT 2019 Intravascular Lithotripsy Shows Good Safety at 30 Days: DISRUPT CAD II Yael L. Maxwell October 08, 2019
Presentation TCT 2019 DISRUPT CAD II: A Single-Arm Study of Intravascular Lithotripsy for Treatment of Severely Calcified Coronary Stenoses Presenter: Carlo Di Mario September 27, 2019
News Conference News AHA 2017 Circling Back on ORBITA: Sham-Controlled PCI Trial Makes Best of 2017 List Michael O'Riordan November 12, 2017
News Conference News ESC 2016 Use of Antithrombotics Instead of Stents Appears Safe, Reduces Thrombus Burden in Subset of ACS Patients: EROSION Michael O'Riordan August 30, 2016